ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

New Recommendations made For Radiation Protection Standards

August 14, 1987

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

In Brief: Ed Moorhead, Community Cancer program Leader, Dies At Age 50; Ficca Appointed NHLBI AO

February 6, 1987

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Three Fourths Of Pediatric Patients are Getting Best Treatment; NCI Goal: Reach all The Others

May 20, 1977